A

Avenue Therapeutics
D

ATXI

1.72000
USD
-0.10
(-5.49%)
مغلق
حجم التداول
542
الربح لكل سهم
-2
العائد الربحي
-
P/E
0
حجم السوق
3,532,748
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AGIO
    0.790
    (2.37%)
    34.060 USD
    A
    ARWR
    -0.050
    (-0.25%)
    19.710 USD
    G
    GLYC
    -0.00260
    (-1.00%)
    0.25740 USD
    I
    INCY
    -1.050
    (-1.43%)
    72.420 USD
    K
    KPTI
    -0.01090
    (-1.60%)
    0.67170 USD
    M
    MGNX
    0.09000
    (3.00%)
    3.09000 USD
    R
    RARE
    1.650
    (4.00%)
    42.950 USD
    S
    SRPT
    -0.920
    (-0.79%)
    116.020 USD
    U
    UTHR
    3.46
    (0.94%)
    371.50 USD
    المزيد
الأخبار
المقالات

العنوان: Avenue Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.